Role of Interleukin-28B Genetic Polymorphisms in Korean Patients with Hepatitis C Virus Infection

• Published in: Gut and liver 2014-01, Vol.8 (1), p.70
• Main Authors: Ho Kil, Sook Hyang Jeong, Jin Wook Kim, Young Sang Byoun, Bo Young Min, Byung Hyun Woo, Jae Lee, Young Seok Kim
• Format: Article
• Language: Korean
• Subjects: Hepatitis C; Interleukin-28B; Korea; Recovery; Treatment
• ISSN: 1976-2283

Background/Aims: This study investigated the role of single nucleotide polymorphisms (SNPs) near the interleukin-28B (IL28B) gene with respect to clinical outcomes and the antiviral response in hepatitis C virus (HCV) infection to suggest the practical utility of IL28B genotyping in Korea. Methods: Two SNPs near IL28B, rs12979860 and rs8099917, were analyzed using an allelic discrimination assay in a total of 454 individuals, including 147 health-check examinees and 307 patients with HCV infection. Results: The CC genotype frequency was significantly higher in the spontaneous recovery group than in the chronic infection group and was higher in the chronic hepatitis group than in the liver cirrhosis or hepatocellular carcinoma group, suggesting its favorable role in the clinical outcome. Multivariate analysis revealed that the rs12979860 CC genotype was an independent predictor of sustained virologic response (SVR) in genotype 1 HCV infection. During the currently used response-guided therapy, IL28B genotyping was most helpful for the patients who exhibit early virologic responses without rapid virologic responses, as those patients exhibiting the non-CC type did not achieve SVR, although they represented approximately one-third of the total patients. Conclusions: The IL28B SNP is an independent predictor of SVR. Our results may be helpful if the findings are carefully applied to select patients in Korea. (Gut Liver 2014,8:70-78)